S
AUTL

SignatureFD’s Autolus Therapeutics AUTL Stock Holding History

SignatureFD’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-346
Closed -$1K – 3104
2022
Q1 		$1K Sell
346
-836
-71% -$3.52K ﹤0.01% 2943
2021
Q4 		$6K Sell
1,182
-2,346
-66% -$14.1K ﹤0.01% 2317
2021
Q3 		$23K Buy
3,528
+3,112
+748% +$19.7K ﹤0.01% 1685
2021
Q2 		$3K Buy
+416
New +$2.58K ﹤0.01% 2420
2020
Q2 		– Sell
-516
Closed -$3K – 2490
2020
Q1 		$3K Buy
+516
New +$4.77K ﹤0.01% 1790

Other funds holding AUTL

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

SignatureFD's AUTL Position: Q2 2022 in Review

SignatureFD sold out of Autolus Therapeutics (AUTL) in Q2 2022, closing a stake of 346 shares — an estimated $1K sold.

SignatureFD first reported a position in AUTL in Q1 2020 and held it in 5 quarters. The position peaked at $23K in Q3 2021. 67 funds tracked by Wall St. Rank hold AUTL as of Q2 2022.

  • SignatureFD reported no remaining Autolus Therapeutics position as of Q2 2022 after selling out during the quarter.
  • SignatureFD sold 346 Autolus Therapeutics shares in Q2 2022, an estimated $1K.
  • SignatureFD first reported a position in Autolus Therapeutics in Q1 2020 and held it in 5 quarters.
  • SignatureFD's Autolus Therapeutics position peaked at $23K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2022.

Based on SignatureFD's 13F filing for Q2 2022, filed 10 Aug 2022.